COPD
COPD (Chronic Obstructive Pulmonary Disease) is a progressive lung disease that makes breathing difficult. It’s often caused by long-term exposure to irritating gases or particles, most notably from cigarette smoke.
Common symptoms include:Shortness of breath, Chronic cough, Wheezing and Mucus production.
The primary cause of COPD is smoking. However, other factors can contribute, including exposure to secondhand smoke,occupational dusts and chemicals, and air pollution.
RAPID GROWTH
COPD is a rapidly growing global health concern, with millions of people affected and thousands dying annually.
Despite the increasing number of patients, recruiting participants for COPD clinical trials remains a significant challenge.
Our company has extensive experience in overcoming these hurdles and successfully enrolling patients in over 30 COPD studies worldwide.
Managing COPD
While there’s no cure for COPD, treatment can help manage symptoms and improve quality of life. This may include:Medications to open airways and reduce inflammation, Pulmonary rehabilitation, Oxygen therapy and Smoking cessation.
COPD is a prevalent lung condition with a significant impact on patients’ lives. While current treatments focus on managing symptoms and preventing exacerbations, a cure remains elusive. Clinical research is essential to develop new therapies. By participating in COPD clinical trials, patients can contribute to medical advancements and potentially benefit from innovative treatments.
We are dedicated to facilitating groundbreaking discoveries, improving patient outcomes, and advancing clinical research solutions.
